World Wires · story 26942 · official · 1 source(s)

8-K: Spyre Therapeutics, Inc. — Item 1.01 Entry into a Material Definitive Agreement

Filed: 2026-10-07 AccNo: 0001628280-26-065291 Size: 590 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibi

Open in the desk

Coverage

• 8-K: Spyre Therapeutics, Inc. — Item 1.01 Entry into a Material Definitive Agreement SEC EDGAR: 8-K material events · tier A · clear net · 2026-10-07 12:00 UTC

What this site indexes